[Home]
[Full version]
Hormone helps mice 'hibernate,' survive starvation
Jun 05 ,General Science
A key hormone enables starving mice to alter their metabolism and “hibernate” to conserve energy, revealing a novel molecular target for drugs to treat human obesity and metabolic disorders, UT Southwestern Medical Center researchers have found.
The starvation-fighting effects of the hormone, called fibroblast growth factor 21 (FGF21), are described for the first time in a study appearing online today in Cell Metabolism.
FGF21, triggered in starving mice by a specific cellular receptor that controls the use of fat as energy, spurs a metabolic shift to burning stored fats instead of carbohydrates and induces a hibernation-like state of decreased body temperature and physical activity, all geared to promote survival.
“This hormone changes the metabolism and behavior of mice in the face of inadequate nutrition,” said Dr. Steven Kliewer, professor of molecular biology and pharmacology at UT Southwestern and the study’s senior author. “We hope to manipulate this hormone-receptor signaling pathway to craft the next generation of drugs to combat human obesity and other conditions.”
Mammals on the brink of starvation normally shift their main fuel source from carbohydrates to stored fats, promoting survival during foodless periods. Some mammals also enter a hibernation-like state of regulated hypothermia, known as torpor, which conserves energy.
The molecular driver behind this reaction to starvation, however, had been unknown.
To find an answer, UT Southwestern researchers and other scientists examined potential molecular cues and cellular interactions at play during starvation and fasting.
They focused on a nuclear receptor – a protein that turns genes on and off in the body – called peroxisome proliferator-activated receptor alpha, or PPAR-alpha, which is known to control the use of fat as energy. Starving mice without PPAR-alpha become hypoglycemic and quickly die.
In analyzing the molecular impact of PPAR-alpha in mice, the researchers found that it stimulates production of FGF21, a member of a hormone family that has been shown to lower blood glucose levels in diabetic and obese mice.
FGF21, in turn, stimulates the use of stored fats as energy and causes torpor.
In properly fed mice, FGF21 is not normally active; however, when the researchers introduced FGF21 into these mice, the animals’ metabolism changed.
“When mice were given this hormone, their metabolism appeared as if they were starved, even after they had just eaten,” said Dr. Kliewer.
Because limiting food consumption is known to have a range of beneficial effects, such as lowering blood pressure, cholesterol and glucose levels in the blood, Dr. Kliewer is interested in understanding how FGF21 impacts these processes.
“We want to see if we can get some benefits of eating less without actually eating less,” he said.
Manipulating the PPAR-alpha-FGF21 signaling pathway might ultimately prove to be a vital part of the ongoing search for new therapies for human obesity and other metabolic conditions, Dr. Kliewer said.
“Given that the PPAR-alpha receptor already is the target of drugs that work to boost high-density lipoproteins, or the ‘good’ cholesterol, and reduce the amount of fat in the blood, we believe this new pathway may lead to a new class of drugs that will impact many human conditions,” he said.
Source: UT Southwestern Medical Center
Related stories:
Olive oil ingredient ups the time between meals
A fatty acid found in abundance in olive oil and other "healthy" unsaturated fats has yet another benefit: it helps keep the body satisfied to prolong the time between meals.
Too many calories send the brain off kilter
An overload of calories throws critical portions of the brain out of whack, reveals a study in the October 3rd issue of the journal
Cell, a Cell Press publication. That response in the brain's hypothalamus—the "headquarters" for maintaining energy balance -- can happen even in the absence of any weight gain, according to the new studies in mice.
Mapping the neuron-behavior link in Rett Syndrome
A link between certain behaviors and the lack of the protein associated with Rett Syndrome – a devastating autism spectrum disorder – demonstrates the importance of MeCP2 (the protein) and reveals never-before recognized functions associated with aggression and obesity, said researchers at Baylor College of Medicine in a report in the current issue of the journal
Neuron.
New class of hormone from 'healthy fat cells' benefits body metabolism in mice
(PhysOrg.com) -- Scientists at the Harvard School of Public Health (HSPH) have identified in mice a newly discovered class of hormones -- lipokines. In tomorrow's issue of the journal
Cell they report that lipokine is a molecule in mice that helps stop, or even reverses obesity-related conditions such as insulin resistance and "fatty liver."
Study suggests why heart attack victims do better with social support
Researchers have identified specific damages to the brain that may occur when heart attack victims are socially isolated from others. The study in mice found that those animals that lived alone before undergoing a heart attack showed five to eight times more damage to neurons in one part of the brain than did similar animals that lived with others.
Gap junction protein vital to successful pregnancy, researchers find
Researchers studying a critical stage of pregnancy – implantation of the embryo in the uterus – have found a protein that is vital to the growth of new blood vessels that sustain the embryo. Without this protein, which is produced in higher quantities in the presence of estrogen, the embryo is unlikely to survive.
Hair on a man's head offers clues about prostate cancer
Some of the drugs given to many men during their fight against prostate cancer can actually spur some cancer cells to grow, researchers have found. The findings were published online this week in a pair of papers in the
Proceedings of the National Academy of Sciences.
Gene's newly explained effect on height may change tumor disorder treatment
A mutation that causes a childhood tumor syndrome also impairs growth hormone secretion, researchers at Washington University School of Medicine in St. Louis have found.
[Home]
[Full version]